Delivery Order SPE2DB22D3301-SPE2DB24FZ2GY

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,937.55, is for the supply of Ondansetron ODT 4 mg tablets in 30-count packages. The contract has an ultimate completion date of January 23, 2024 and is a firm-fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,167.93, is for the delivery of 4,563,362,847 units of the medication Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price, has no set-aside designation, and has a completion date of January 22, 2024. AmerisourceBergen holds a $999,999,999 IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $32,410.81 and a completion date of July 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,958.64, is for the supply of Ondansetron ODT 4 mg tablets and has a completion date of November 21, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,345.98 firm fixed-price contract is for the supply of Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of February 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,816.52, is for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 tablets per bottle. The contract is a firm fixed-price, delivery order with an ultimate completion date of February 11, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,935.36, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has a completion date of January 23, 2025 and utilizes a firm fixed price pricing type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,209.49, is for the delivery of ondansetron ODT 4 mg tablets. It is a firm fixed-price contract that runs through January 23, 2025. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,778.69, is for the supply of Ondansetron ODT 8 mg tablets. The contract is a firm fixed-price delivery order with a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,612.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,401,649 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2GY
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $1,598.48. The contract is for the supply of 4565366863 - Ondansetron ODT 4 MG Tablets in 30-count packages. The contract has a firm fixed price pricing type and an ultimate completion date of August 7, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical supplies. These IDCs serve as primary vehicles for the company to deliver critical care items and medications to support military treatment programs and other federal healthcare needs.

Generated 11/5/24, 9:15 AM